• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-Xa Activity-Guided Edoxaban Therapy for Cancer-Associated Venous Thromboembolism?

作者信息

Samoš Matej, Bolek Tomáš, Škorňová Ingrid, Benko Jakub, Stančiaková Lucia, Grilusová Kristína, Galajda Peter, Stasko Ján, Kubisz Peter, Mokáň Marián

机构信息

Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.

Department of Hematology and Blood Transfusion, National Centre of Hemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic.

出版信息

Am J Ther. 2022;29(6):e754-e757. doi: 10.1097/MJT.0000000000001202. Epub 2020 May 25.

DOI:10.1097/MJT.0000000000001202
PMID:32496437
Abstract
摘要

相似文献

1
Anti-Xa Activity-Guided Edoxaban Therapy for Cancer-Associated Venous Thromboembolism?抗Xa活性指导下的依度沙班治疗癌症相关静脉血栓栓塞？
Am J Ther. 2022;29(6):e754-e757. doi: 10.1097/MJT.0000000000001202. Epub 2020 May 25.
2
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.依度沙班用于癌症患者静脉血栓栓塞症：来自北斋-VTE随机、双盲、双模拟试验的非劣效性亚组分析结果
Lancet Haematol. 2016 Aug;3(8):e379-87. doi: 10.1016/S2352-3026(16)30057-6. Epub 2016 Jul 1.
3
Direct factor Xa inhibitor edoxaban: from bench to clinical practice.直接凝血因子Xa抑制剂依度沙班：从实验室到临床实践
Expert Rev Hematol. 2015 Dec;8(6):707-25. doi: 10.1586/17474086.2015.1111756. Epub 2015 Nov 11.
4
Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism.Xa 抑制剂治疗癌症相关静脉血栓栓塞症的疗效和安全性。
Expert Opin Drug Saf. 2019 Apr;18(4):313-320. doi: 10.1080/14740338.2019.1601699. Epub 2019 Apr 8.
5
Edoxaban: A Novel Factor Xa Inhibitor for the Management of Non-valvular Atrial Fibrillation and Venous Thromboembolism.依度沙班：一种用于治疗非瓣膜性心房颤动和静脉血栓栓塞症的新型Xa因子抑制剂。
Cardiol Rev. 2016 Jul-Aug;24(4):205-10. doi: 10.1097/CRD.0000000000000104.
6
Edoxaban: How Does the Newest Agent Fit into the DOAC Landscape?依度沙班：最新药物如何融入直接口服抗凝药格局？
Am J Med. 2017 Aug;130(8):900-906. doi: 10.1016/j.amjmed.2017.02.048. Epub 2017 Apr 6.
7
Can I use direct oral anticoagulants to treat cancer-associated venous thromboembolism?我可以使用直接口服抗凝剂治疗癌症相关的静脉血栓栓塞症吗？
Cleve Clin J Med. 2020 Apr;87(4):201-203. doi: 10.3949/ccjm.87a.19100.
8
Factor Xa inhibitors in the prevention of cancer-related venous thromboembolism: lessons learned by clinical trials.Xa因子抑制剂在预防癌症相关静脉血栓栓塞中的应用：临床试验的经验教训
Future Oncol. 2020 Nov;16(32):2591-2594. doi: 10.2217/fon-2020-0696. Epub 2020 Aug 17.
9
Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer.口服直接Xa因子抑制剂依度沙班对有癌症和无癌症患者静脉血栓栓塞影响的比较。
J Cardiol. 2018 Aug;72(2):120-127. doi: 10.1016/j.jjcc.2018.03.006. Epub 2018 Apr 13.
10
[Not Available].[无可用内容]
Lakartidningen. 2018 Dec 4;115:FAS3.